These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 6745430)
1. Thymidylate synthetase-positive and -negative murine mammary FM3A carcinoma cells as a useful system for detecting thymidylate synthetase inhibitors. Balzarini J; de Clercq E; Ayusawa D; Seno T FEBS Lett; 1984 Jul; 173(1):227-32. PubMed ID: 6745430 [TBL] [Abstract][Full Text] [Related]
2. Incorporation of 5-substituted pyrimidine nucleoside analogues into DNA of a thymidylate synthetase-deficient murine FM3A carcinoma cell line. Balzarini J; De Clercq E; Ayusawa D; Seno T Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):19-28. PubMed ID: 3990443 [TBL] [Abstract][Full Text] [Related]
3. Thymidylate synthetase-deficient mouse FM3A mammary carcinoma cell line as a tool for studying the thymidine salvage pathway and the incorporation of thymidine analogues into host cell DNA. Balzarini J; De Clercq E; Ayusawa D; Seno T Biochem J; 1984 Jan; 217(1):245-52. PubMed ID: 6696722 [TBL] [Abstract][Full Text] [Related]
4. 5-Substituted 2'-deoxyuridines: correlation between inhibition of tumor cell growth and inhibition of thymidine kinase and thymidylate synthetase. Balzarini J; De Clercq E; Mertes MP; Shugar D; Torrence PF Biochem Pharmacol; 1982 Nov; 31(22):3673-82. PubMed ID: 7181950 [TBL] [Abstract][Full Text] [Related]
5. Modulation of anti-metabolite effects. Effects of thymidine on the efficacy of the quinazoline-based thymidylate synthetase inhibitor, CB3717. Jackman AL; Taylor GA; Calvert AH; Harrap KR Biochem Pharmacol; 1984 Oct; 33(20):3269-75. PubMed ID: 6487375 [TBL] [Abstract][Full Text] [Related]
6. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene. Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092 [TBL] [Abstract][Full Text] [Related]
7. Role of thymidine kinase and thymidylate synthetase in the cytostatic, antimetabolic, and antitumor effects of the carbocyclic analogue of 5-nitro-2'-deoxyuridine. A comparison with 5-nitro-2'-deoxyuridine. Balzarini J; De Clercq E; Herdewijn P; Robins MJ Mol Pharmacol; 1985 May; 27(5):578-83. PubMed ID: 3990680 [TBL] [Abstract][Full Text] [Related]
8. Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine derivatives for murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 thymidine kinase gene. Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Seno T Mol Pharmacol; 1985 Dec; 28(6):581-7. PubMed ID: 3001499 [TBL] [Abstract][Full Text] [Related]
9. Resistance to methotrexate in thymidylate synthetase-deficient mutants of cultured mouse mammary tumor FM3A cells. Ayusawa D; Koyama H; Seno T Cancer Res; 1981 Apr; 41(4):1497-501. PubMed ID: 6452198 [TBL] [Abstract][Full Text] [Related]
10. Thymidylate synthetase as target enzyme for the inhibitory activity of 5-substituted 2'-deoxyuridines on mouse leukemia L1210 cell growth. De Clercq E; Balzarini J; Torrence PF; Mertes MP; Schmidt CL; Shugar D; Barr PJ; Jones AS; Verhelst G; Walker RT Mol Pharmacol; 1981 Mar; 19(2):321-30. PubMed ID: 7231392 [No Abstract] [Full Text] [Related]
11. Antiviral, antitumor, and thymidylate synthetase inhibition studies of 5-substituted styryl derivatives of 2'-deoxyuridine and their 5'-phosphates. De Clercq E; Balzarini J; Descamps J; Bigge CF; Chang CT; Kalaritis P; Mertes MP Biochem Pharmacol; 1981 Mar; 30(5):495-502. PubMed ID: 6261769 [No Abstract] [Full Text] [Related]
13. Cytotoxicity of 5-nitro-2'-deoxyuridine by in vivo inhibition of thymidylate synthetase. Washtien W; Matsuda A; Wataya Y; Santi DV Biochem Pharmacol; 1978; 27(22):2663-6. PubMed ID: 215163 [No Abstract] [Full Text] [Related]
14. Synthesis of 5-selenium-substituted uracil derivatives. Inhibition of thymidylate synthetase by 5-hydroseleno-2'-deoxyuridylate. Choi S; Kalman TI; Bardos TJ J Med Chem; 1979 Jun; 22(6):618-21. PubMed ID: 110931 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of mammalian tumour thymidylate synthetase by 5-alkylated 2'-deoxyuridine 5'-phosphates. Rode W; Kulikowski T; Kedzierska B; Jastreboff M; Shugar D Biochem Pharmacol; 1984 Sep; 33(17):2699-705. PubMed ID: 6466380 [TBL] [Abstract][Full Text] [Related]
16. Biochemical effects of a quinazoline inhibitor of thymidylate synthetase, N-(4-(N-(( 2-amino-4-hydroxy-6-quinazolinyl)methyl)prop-2-ynylamino) benzoyl)-L-glutamic acid (CB3717), on human lymphoblastoid cells. Jackson RC; Jackman AL; Calvert AH Biochem Pharmacol; 1983 Dec; 32(24):3783-90. PubMed ID: 6661252 [TBL] [Abstract][Full Text] [Related]
17. Strategies for the measurement of the inhibitory effects of thymidine analogs on the activity of thymidylate synthase in intact murine leukemia L1210 cells. Balzarini J; De Clercq E Biochim Biophys Acta; 1984 Feb; 785(1-2):36-45. PubMed ID: 6696920 [TBL] [Abstract][Full Text] [Related]
18. 5-Nitro-2'-deoxyuridine and 5-nitro-2'-deoxyuridine 5'-monophosphate: antiviral activity and inhibition of thymidylate synthetase in vivo. De Clercq E; Descamps J; Huang GF; Torrence PF Mol Pharmacol; 1978 May; 14(3):422-30. PubMed ID: 661811 [No Abstract] [Full Text] [Related]